169 related articles for article (PubMed ID: 36613859)
1. Impact on the Clinical Evolution of Patients with COVID-19 Pneumonia and the Participation of the
Soto ME; Fuentevilla-Álvarez G; Palacios-Chavarría A; Vázquez RRV; Herrera-Bello H; Moreno-Castañeda L; Torres-Paz YE; González-Moyotl NJ; Pérez-Torres I; Aisa-Alvarez A; Manzano-Pech L; Pérez-Torres I; Huesca-Gómez C; Gamboa R
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613859
[TBL] [Abstract][Full Text] [Related]
2. Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population.
Siedlinski M; Postma DS; Boer JM; van der Steege G; Schouten JP; Smit HA; Boezen HM
Respir Res; 2009 Aug; 10(1):73. PubMed ID: 19671143
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma.
Goeman F; De Nicola F; Scalera S; Sperati F; Gallo E; Ciuffreda L; Pallocca M; Pizzuti L; Krasniqi E; Barchiesi G; Vici P; Barba M; Buglioni S; Casini B; Visca P; Pescarmona E; Mazzotta M; De Maria R; Fanciulli M; Ciliberto G; Maugeri-Saccà M
J Thorac Oncol; 2019 Nov; 14(11):1924-1934. PubMed ID: 31323387
[TBL] [Abstract][Full Text] [Related]
4. Association of KEAP1 and NFE2L2 polymorphisms with temporal lobe epilepsy and drug resistant epilepsy.
Liu Z; Yin X; Liu L; Tao H; Zhou H; Ma G; Cui L; Li Y; Zhang S; Xu Z; Yao L; Cai Z; Zhao B; Li K
Gene; 2015 Oct; 571(2):231-6. PubMed ID: 26149655
[TBL] [Abstract][Full Text] [Related]
5. Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis.
Bergström P; von Otter M; Nilsson S; Nilsson AC; Nilsson M; Andersen PM; Hammarsten O; Zetterberg H
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):130-7. PubMed ID: 24102512
[TBL] [Abstract][Full Text] [Related]
6. KEAP1 polymorphisms and neurodevelopmental outcomes in children with exposure to prenatal MeHg from the Seychelles Child Development Study Nutrition Cohort 2.
de Paula HK; Love TM; Pineda D; Watson GE; Thurston SW; Yeates AJ; Mulhern MS; McSorley EM; Strain JJ; Shamlaye CF; Myers GJ; Rand MD; van Wijngaarden E; Broberg K
Neurotoxicology; 2023 Dec; 99():177-183. PubMed ID: 37858899
[TBL] [Abstract][Full Text] [Related]
7. Kelch-like ECH-associated protein 1 (KEAP1) differentially regulates nuclear factor erythroid-2-related factors 1 and 2 (NRF1 and NRF2).
Tian W; Rojo de la Vega M; Schmidlin CJ; Ooi A; Zhang DD
J Biol Chem; 2018 Feb; 293(6):2029-2040. PubMed ID: 29255090
[TBL] [Abstract][Full Text] [Related]
8. Survival Outcomes and Treatment Patterns in Patients With NFE2L2 and/or KEAP1 Mutation-Positive Advanced Squamous Cell NSCLC Using a Real-World Clinico-Genomic Database.
Wu Y; Yin Y; Crossland V; Vincent S; Paik PK; Lineberry N; Faller DV
Clin Lung Cancer; 2022 Sep; 23(6):487-497. PubMed ID: 35705448
[TBL] [Abstract][Full Text] [Related]
9. Associations of the NRF2/KEAP1 pathway and antioxidant defense gene polymorphisms with chronic obstructive pulmonary disease.
Korytina GF; Akhmadishina LZ; Aznabaeva YG; Kochetova OV; Zagidullin NS; Kzhyshkowska JG; Zagidullin SZ; Viktorova TV
Gene; 2019 Apr; 692():102-112. PubMed ID: 30641209
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Pathological Characteristics of
Frank R; Scheffler M; Merkelbach-Bruse S; Ihle MA; Kron A; Rauer M; Ueckeroth F; König K; Michels S; Fischer R; Eisert A; Fassunke J; Heydt C; Serke M; Ko YD; Gerigk U; Geist T; Kaminsky B; Heukamp LC; Clement-Ziza M; Büttner R; Wolf J
Clin Cancer Res; 2018 Jul; 24(13):3087-3096. PubMed ID: 29615460
[No Abstract] [Full Text] [Related]
11. SARS-CoV-2 ORF3a sensitizes cells to ferroptosis via Keap1-NRF2 axis.
Liu L; Du J; Yang S; Zheng B; Shen J; Huang J; Cao L; Huang S; Liu X; Guo L; Li C; Ke C; Peng X; Guo D; Peng H
Redox Biol; 2023 Jul; 63():102752. PubMed ID: 37245288
[TBL] [Abstract][Full Text] [Related]
12. KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC.
Arolt C; Dugan M; Wild R; Richartz V; Holz B; Scheel AH; Brägelmann J; Wagener-Ryczek S; Merkelbach-Bruse S; Wolf J; Buettner R; Catanzariti L; Scheffler M; Hillmer AM
J Thorac Oncol; 2023 Nov; 18(11):1550-1567. PubMed ID: 37473958
[TBL] [Abstract][Full Text] [Related]
13. NFE2L2/KEAP1 Mutations Correlate with Higher Tumor Mutational Burden Value/PD-L1 Expression and Potentiate Improved Clinical Outcome with Immunotherapy.
Xu X; Yang Y; Liu X; Cao N; Zhang P; Zhao S; Chen D; Li L; He Y; Dong X; Wang K; Lin H; Mao N; Liu L
Oncologist; 2020 Jun; 25(6):e955-e963. PubMed ID: 32272498
[TBL] [Abstract][Full Text] [Related]
14. Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non-Small Cell Lung Cancer.
Jeong Y; Hellyer JA; Stehr H; Hoang NT; Niu X; Das M; Padda SK; Ramchandran K; Neal JW; Wakelee H; Diehn M
Clin Cancer Res; 2020 Jan; 26(1):274-281. PubMed ID: 31548347
[TBL] [Abstract][Full Text] [Related]
15. KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes.
Hartikainen JM; Tengström M; Winqvist R; Jukkola-Vuorinen A; Pylkäs K; Kosma VM; Soini Y; Mannermaa A
Clin Cancer Res; 2015 Apr; 21(7):1591-601. PubMed ID: 25589623
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs.
Fabrizio FP; Sparaneo A; Trombetta D; Muscarella LA
Oxid Med Cell Longev; 2018; 2018():2492063. PubMed ID: 29643973
[TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic regulation of the NRF2-KEAP1 pathway in human lung cancer.
Camiña N; Penning TM
Br J Cancer; 2022 May; 126(9):1244-1252. PubMed ID: 34845361
[TBL] [Abstract][Full Text] [Related]
18. Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress.
Suzuki T; Yamamoto M
J Biol Chem; 2017 Oct; 292(41):16817-16824. PubMed ID: 28842501
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic modifications but not genetic polymorphisms regulate KEAP1 expression in colorectal cancer.
Gao L; Yuan F; Che G; Xiao X; Nie X; Wang Y; Jia J; Kong AN; Zhang L
J Cell Biochem; 2019 Aug; 120(8):12311-12320. PubMed ID: 30825237
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2-Keap1 interaction: Activation of antioxidative pathway in papillary thyroid carcinoma.
Danilovic DLS; de Mello ES; Frazzato EST; Wakamatsu A; de Lima Jorge AA; Hoff AO; Marui S
Head Neck; 2018 Jun; 40(6):1271-1278. PubMed ID: 29469959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
